BAD Antikörper (C-Term, pSer155)
-
- Target Alle BAD Antikörper anzeigen
- BAD (BCL2-Associated Agonist of Cell Death (BAD))
-
Bindungsspezifität
- C-Term, pSer155
-
Reaktivität
- Human, Affe
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BAD Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunochromatography (IC)
- Spezifität
- Recognizes endogenous levels of BAD (pS155) protein.
- Produktmerkmale
- Rabbit polyclonal antibody to BAD (pS155)
- Aufreinigung
- The antibody was purified by immunogen affinity chromatography.
- Immunogen
- KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human BAD.
- Top Product
- Discover our top product BAD Primärantikörper
-
-
- Applikationshinweise
- WB (1:500 - 1:1000), IH (1:100 - 1:200), IF/IC (1:100 - 1:500)
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- BAD (BCL2-Associated Agonist of Cell Death (BAD))
- Andere Bezeichnung
- BAD (BAD Produkte)
- Hintergrund
- BBC6, BCL2L8, Bcl2 antagonist of cell death, BAD, Bcl-2-binding component 6, Bcl-2-like protein 8, Bcl2-L-8, Bcl-XL/Bcl-2-associated death promoter
- Gen-ID
- 572, 12015, 64639
- UniProt
- Q92934, Q61337, O35147
- Pathways
- MAPK Signalweg, PI3K-Akt Signalweg, RTK Signalweg, Apoptose, Fc-epsilon Rezeptor Signalübertragung, Positive Regulation of Peptide Hormone Secretion, Carbohydrate Homeostasis, Positive Regulation of Endopeptidase Activity, Regulation of Carbohydrate Metabolic Process, Hepatitis C, CXCR4-mediated Signaling Events
-